Form S-1 - General form for registration of securities under the Securities Act of 1933:
SEC Accession No. 0001641172-25-010013
Filing Date
2025-05-13
Accepted
2025-05-13 17:21:07
Documents
70

Document Format Files

Seq Description Document Type Size
1 S-1 forms-1.htm   iXBRL S-1 2794010
2 EX-5.1 ex5-1.htm EX-5.1 12144
3 EX-23.1 ex23-1.htm EX-23.1 10564
4 EX-23.2 ex23-2.htm EX-23.2 3305
5 EX-FILING FEES ex107.htm EX-FILING FEES 29370
6 GRAPHIC ex5-1_001.jpg GRAPHIC 6327
7 GRAPHIC ex23-1_001.jpg GRAPHIC 7320
  Complete submission text file 0001641172-25-010013.txt   8561776

Data Files

Seq Description Document Type Size
8 XBRL SCHEMA FILE asbp-20241231.xsd EX-101.SCH 55007
9 XBRL CALCULATION FILE asbp-20241231_cal.xml EX-101.CAL 46730
10 XBRL DEFINITION FILE asbp-20241231_def.xml EX-101.DEF 378380
11 XBRL LABEL FILE asbp-20241231_lab.xml EX-101.LAB 388182
12 XBRL PRESENTATION FILE asbp-20241231_pre.xml EX-101.PRE 379318
72 EXTRACTED XBRL INSTANCE DOCUMENT forms-1_htm.xml XML 942366
Mailing Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791
Business Address 194 CANDELARO DRIVE, #233 HUMACAO PR 00791 561-704-8527
Aspire Biopharma Holdings, Inc. (Filer) CIK: 0001847345 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: S-1 | Act: 33 | File No.: 333-287240 | Film No.: 25941439
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)